Biocon's social responsibility initiative ‘ABIDE’, a unique diabetes education initiative for medical practitioners, which has been making a significant impact across the country, has now been conferred with the 'Award of Recognition' for its benefits, coverage and impeccable quality of delivery by the prestigious Research Society for the Study of Diabetes in India (RSSDI).
ABIDE is a 'paradigm-shifting' initiative designed to empower primary care physicians who treat diabetes on a regular basis. The courses are delivered in a non-commercial setting and offer learning opportunities through 'experience sharing' during the intensive deliberations in small group engagements. The pragmatic and application-based approach of ABIDE has helped physicians improve their practice with enriched patient connect and enhanced clinical outcomes. Biocon plans to expand the ambit of the ABIDE program for the benefit of a wider group of healthcare providers.
Biocon is India's largest and fully-integrated, innovation-led biopharmaceutical company.
